## Note
nid: 1517958608575
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Pathoma_Chapter_3_(Neoplasia), #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::09_Tumor_Suppressor_Genes, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::09_Tumor_Suppressor_Genes::CDKN2A, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pathoma::03_Neoplasia::02_Carcinogenesis::2_Oncogenes, #AK_Step1_v11::#Pathoma::03_Neoplasia_Alt_Tagging::BlueGalaxies::02_Carcinogenesis::2_Oncogenes, #AK_Step1_v11::#Physeo::11_Pathology::07_General_Pathology::09_Carcinogenesis, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^FA_Updates::FA2018
markdown: false

### Text
The tumor suppressors encoded by the <b>CDKN2A</b> gene enforce the
G1-->S restriction point by:
<div>
  <div>
    <div>
      (1) - inhibiting CDK{{c1::4}}/{{c1::6}}
    </div>
    <div>
      (2) - relieving inhibition of {{c2::P53}}
    </div>
  </div>
</div>

### Extra
(1) this is done via the P16 protein encoded by CDKN2A
<div>
  <div>
    (2) CDKN2A also encodes P14arf, which inhibits MDM2 (the
    regulator of P53)
  </div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

